Finance
Beta
search
Search or ask
settings
Theme
mobile
Device default
✓
dark_mode
Dark theme
light_mode
Light theme
Search labs
feedback
Send feedback
Sign in
Lists
playlist_add
New
FEBU
Research
FEBU:BATS
check_indeterminate_small
AllianzIM US Equity Buffer15 Uncapped Feb ETF
$29.64
arrow_downward
-0.18%
(
-0.054
) 1D
Jul 1, 4:00:00 PM GMT-4 · USD
area_chart
Area
stacked_line_chart
Compare
search
close
All symbols
monitoring
Indicators
No data
1D
5D
1M
6M
YTD
1Y
5Y
MAX
Symbol
Price
Change
% Change
Overview
insights_auto
Generating top insights for FEBU...
Open
$29.69
High
$29.69
Low
$29.64
Avg. vol.
2.43K
Volume
0.00
52-wk high
$30.15
52-wk low
$25.60
Open
$29.69
High
$29.69
Low
$29.64
Avg. vol.
2.43K
Volume
0.00
52-wk high
$30.15
52-wk low
$25.60
Related assets
MARU
AllianzIM US Equity Buffer15 Uncapped Mar ETF
$29.61
-0.25%
arrow_downward
JANU
AllianzIM US Equity Buffer15 Uncapped Jan ETF
$30.04
-0.29%
arrow_downward
OCTU
AllianzIM US Equity Buffer15 Uncapped Oct ETF
$30.34
-0.27%
arrow_downward
MAYU
AllianzIM US Equity Buffer15 Uncapped May ETF
$34.08
-0.17%
arrow_downward
News stories
From sources across the web
Karyopharm
·
13 minutes ago
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Stock Titan
·
19 minutes ago
Syndax awards stock options to 8 new hires in July
www.marketscreener.com
·
19 minutes ago
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance
·
28 minutes ago
Market expert sees S&P hitting 7,900 this year
Show more
AI content may include mistakes.
Learn more
Help
Send feedback
Privacy
Terms
Disclaimer
Research
edit_square
New thread
notes_spark
Thread history
close
Collapse
expand_content
Expand
What's on your mind?
What's going on with the markets today?
search_spark
Explore what’s possible
travel_explore
Deep Search
mic
Voice Search
add
Add Tool
upload_file
Upload File
travel_explore
Deep Search
arrow_upward
Ask AI
search_spark
mic
Voice Search
AI content may include mistakes.
Learn more
Help
Send feedback
Privacy
Terms
Disclaimer